Maravai LifeSciences Holdings Inc expected to post a loss of 3 cents a share - Earnings Preview

Maravai Lifesciences Holdings

07/05/2024 03:26

* Maravai LifeSciences Holdings Inc  MRVI.OQ   MRVI.O  is
expected
to show a fall in quarterly revenue when it reports  results on
May 8 for the period ending March 31 2024
    * The San Diego California-based  company is expected to
report a
23.4% decrease in revenue to $60.548 million from $79.03 million
a year ago, according to the mean estimate from 10 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Maravai LifeSciences
Holdings
Inc is for a loss of 3 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 7.1%
in the last three months. ​
    * Wall Street's median 12-month price target for Maravai
LifeSciences Holdings Inc is $9.13​, above​ its last closing
price of $9.01. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Dec. 31 2023  -0.01       -0.01      0.01      Beat    184.6
 Sep. 30 2023  0.00        0.01       -0.01     Missed  -257.2
 Jun. 30 2023  0.01        0.01       0.00      Missed  -100​
 Mar. 31 2023  0.04        0.04       0.03      Missed  -17.2
 ​​Dec.        0.35        0.34       0.35      Beat    2.4
 31 2022                                                
 Jan. 1 0001   0.33        0.33       0.37      Beat    12.2​
 Jun. 30 2022  0.45        0.45       0.54      Beat    18.8
 Mar. 31 2022  0.44        0.44       0.54      Beat    23
 This summary was machine generated May 7 at 02:26 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)